analysed for different diseases and sensitivity to medication. The results, which revealed risks of heart disease, diabetes and prostate cancer, could pave the way to similar tests for the general public."
The Daily Mirror on the same day was equally succinct, but at the same time both more and less informative: "A scientist has become the first person in the world to have his DNA screened. In a study published in The Lancet Prof Stephen Quake, a bioengineer at Stanford University, California, was examined for 55 conditions, ranging from type 2 diabetes to schizophrenia. But in another article heart scientist Prof Nilesh Samani, of Leicester University, wrote of ethical issues -'who should have their genome sequenced, what counselling be provided and who should have access to an individual's genetic information'".
At the other extreme, The Independent allocated an entire page to a report on the scientific work plus a background commentary by science editor Jeremy Laurance. An excellent graphic highlighted nine different conditions, the risk in each case faced by Quake and the average risk for men of his age in the general population. For example, his risks of developing obesity, heart disease, diabetes and depression were 63%, 58%, 55% and 25%, respectively, as compared with average figures of 25%, 50%, 27% and 10%.
Both the news report and commentary referred to wider aspects of the development and wider application of genome analysis. Laurance explained how it can provide information to help individuals live with increased susceptibility to particular maladies (as Quake has done by beginning to take statins to prevent cardiovascular disease). The new technique will also help doctors to encourage patients predisposed to lung cancer to stop smoking, and those prone to obesity or diabetes to moderate their diets.
In other cases, Laurance pointed out, the provision of genetic information could be positively harmful, the only outcome being that an affected individual would have to live under the shadow of a threatened disease. "Analysis of your genome could reveal you were carrying a gene for Huntingdon's disease, a condition that kills people in their 20s and for which there is no treatment. Would there be benefit in that?"
Dwarfed by a headline "The DNA death test", the Daily Mail carried a similar chart (with most of the percentages different from those in The Independent, but with the same general relative risks). Medical correspondent Jenny Hope pointed out that we are rapidly approaching an era when everyone will be able to have their DNA scanned for evidence of disease propensities. She said that tests already available commercially at around £300 can read part of a person's genome, and that others costing $2,000 (£1,300) give verdicts on the risks of 50 common diseases.
"Cardiologist Euen Ashley, one of the Stanford scientists, said the falling cost of genome sequencing would soon put screening of the full code within reach of the general public." The $1,000 (£657) genome was coming fast. The challenge was in knowing what to do with all that information.
"Professor Henry Greely, from Stanford Law School, said patients, doctors and geneticists are about to be hit by a 'tsunami' of genetic data. 'We predict that an average person might need information about roughly 100 genetic risks,' he said. He warned that it would take at least five hours to counsel the average patient about their genetic risks of disease, in addition to many hours of analysis to assess the nature of the risks."
The Guardian did most to explain the science behind the announcement. "The scientists began by building a data-base of gene variants and their links to medical conditions," science correspondent Ian Sample wrote. "Atul Butte, who worked on the study, said: 'We read thousands of publications and made a list of every single spot in the genome where we know that, for example, the letter A raises the risk of a particular disease, or the letter T confers protection.'" Although news editors had dramatically different feelings about the importance of this story, those who did cover it were united in one thing. None of them invoked those ethicists and commentators who can be relied upon to voice dire warnings about most advances in biomedicine. Good.
Bernard Dixon is the European editor of the American Society for Microbiology.
For the first time in more than 30 years, the outcome of Britain's general election earlier this month failed to deliver an outright victory to one party and a liberal -conservative coalition has emerged. Europe is in the grip of debt troubles and voters may have been unsure of who may be best at handling the problem.
While eyes have been focused on Greece and the enormous bail-out loans agreed by other European states to help the country prevent defaulting on its debt, other commentators pointed out that the UK's budget deficit is far larger than that of Greece.
On the eve of the election the European Commission predicted that the British deficit for this calendar year would be 12 per cent of GDP, the highest of all the 27 EU nations. The country's budget shortfall was the third largest in the EU last year but is now set to overtake both Greece and Ireland. Greece's painful measures, which have sparked so much protest, are estimated to reduce its deficit to 9.3 per cent of GDP.
With such a serious budget shortfall facing the new British government, it is inevitable that science, higher education and health will face their share of wider cutbacks.
Indeed, The Times reported the governor of the Bank of England, Mervyn King, saying before the election that the austerity measures needed to tackle Britain's budget deficit would be so unpopular that whoever won the election would not get back into government for a generation.
Science has generally fared quite well under the last Labour government, but the mood had begun to change in recent years as the budget problems loomed. The government's pre-budget report in December last year announced that £600 million would be cut from higher education and science and research budgets by 2012-13.
The prospect of budget cuts prompted the House of Commons science and technology committee to launch an enquiry earlier this year to examine likely impacts.
Science and health will not be immune from the deep spending cuts the new British government must now implement. Nigel Williams reports.
The cuts begin here
and Liberal Democrat parties, at the meeting, said they had no plans to cut the 2010-11 science budget.
Science funding has supposedly been within a ring fence over recent years but the current situation is due to expire in this financial year. Afriyie said the Conservatives were committed to allocating a "multi-year ring-fenced science budget".
But some researchers remain worried about Conservative plans. In a letter to The Independent last month a group of researchers including senior figures such as Sir Paul Nurse, virologist Robin Weiss and physicist Ken Pounds highlighted earlier comments that the Conservatives were a "vision-free zone" and "their continuing failure to address this critique is making us concerned that this lack of vision actually reflects a lack of commitment. Our economic recovery depends on sustaining and utilising Britain's position in global science."
But on the eve of the election, lecturers from 14 universities and colleges staged a one-day strike in protest over cuts. The University and College Union, which organised the protest, said that English universities face funding cuts of 1.1 per cent although they are receiving record numbers of applications for courses -16.5 per cent up compared with last year.
And the National Health Service, which also carries out substantial amounts of research and assessment of new treatments, is braced for cuts.
The Times reported that the number of health bodies seeking advice for big changes, including possible closures, had doubled over the past year.
Experts suggest that the NHS will be structured around fewer, larger hubs of specialist services with many more 'outreach' units in local communites in a move away from the district-hospital model at present.
Regardless of the shape of Britain's new government, if Mervyn King is to be believed, science, health and higher education funding is, indeed, set for troubled times.
In its report, published in March, it concluded that the government should "commit to an increase in investment in science now or risk devastating British science and the economy in years to come." But such pleas are likely to make little impact on the realities facing the new government. Before the election, the lobby group Campaign for Science and Engineering in the UK (CASE) had questioned the three main parties on science policy. Adam Afriyie, the Conservative shadow minister for innovation, universities and skills, said: "Our science base is a valuable national assest. Economically, politically and socially, it underpins the prosperity and well-being of our nation."
But in comments reported in the Times Higher Education, Afriyie, speaking at a cross-party debate on science in London, said that he would 'hold a party' if the Conservatives managed to maintain spending in the short term. "These are troubled times," he said. Both the Labour Cutbacks: Health Service and science budgets will be under scrutiny by Britain's new government given the country's serious budget deficit. Photo: Keith Morris/Alamy.)
